4AOF
Selective small molecule inhibitor discovered by chemoproteomic assay platform reveals regulation of Th17 cell differentiation by PI3Kgamma
Summary for 4AOF
Entry DOI | 10.2210/pdb4aof/pdb |
Related | 1E8Y 1E8Z 1HE8 2A4Z 2A5U 2CHW 2CHX 2CHZ 2V4L 3ZVV 3ZW3 4ANU 4ANV 4ANW 4ANX |
Descriptor | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM, N-[6-(5-methylsulfonylpyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]ethanamide (3 entities in total) |
Functional Keywords | transferase |
Biological source | HOMO SAPIENS (HUMAN) |
Cellular location | Cytoplasm: P48736 |
Total number of polymer chains | 1 |
Total formula weight | 110229.55 |
Authors | Bergamini, G.,Bell, K.,Shimamura, S.,Werner, T.,Cansfield, A.,Muller, K.,Perrin, J.,Rau, C.,Ellard, K.,Hopf, C.,Doce, C.,Leggate, D.,Mangano, R.,Mathieson, T.,OMahony, A.,Plavec, I.,Rharbaoui, F.,Reinhard, F.,Savitski, M.M.,Ramsden, N.,Hirsch, E.,Drewes, G.,Rausch, O.,Bantscheff, M.,Neubauer, G. (deposition date: 2012-03-26, release date: 2012-05-09, Last modification date: 2023-12-20) |
Primary citation | Bergamini, G.,Bell, K.,Shimamura, S.,Werner, T.,Cansfield, A.,Muller, K.,Perrin, J.,Rau, C.,Ellard, K.,Hopf, C.,Doce, C.,Leggate, D.,Mangano, R.,Mathieson, T.,O'Mahony, A.,Plavec, I.,Rharbaoui, F.,Reinhard, F.,Savitski, M.M.,Ramsden, N.,Hirsch, E.,Drewes, G.,Rausch, O.,Bantscheff, M.,Neubauer, G. A Selective Inhibitor Reveals Pi3Kgamma Dependence of T(H)17 Cell Differentiation. Nat.Chem.Biol., 8:576-, 2012 Cited by PubMed Abstract: We devised a high-throughput chemoproteomics method that enabled multiplexed screening of 16,000 compounds against native protein and lipid kinases in cell extracts. Optimization of one chemical series resulted in CZC24832, which is to our knowledge the first selective inhibitor of phosphoinositide 3-kinase γ (PI3Kγ) with efficacy in in vitro and in vivo models of inflammation. Extensive target- and cell-based profiling of CZC24832 revealed regulation of interleukin-17-producing T helper cell (T(H)17) differentiation by PI3Kγ, thus reinforcing selective inhibition of PI3Kγ as a potential treatment for inflammatory and autoimmune diseases. PubMed: 22544264DOI: 10.1038/NCHEMBIO.957 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.3 Å) |
Structure validation
Download full validation report